A Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic Cancer

Clinical trial NCT03212469 · COMPLETED

Trial details

NCT number: NCT03212469
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma Lung Cancer Oesophageal Cancer

Start date: 2017-06-20
Primary completion: 2025-02-24
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.